C-reactive protein alone or combined with cardiac troponin T for risk stratification of respiratory intensive care unit patients

Respiratory Care

Volumn 56, Issue 7, 2011, Pages 1002-1008

  Ozsu, Savas ^a   Yilmaz, Gurdal ^a   Yilmaz, Ismail ^a   Oztuna, Funda ^a   Bulbul, Yilmaz ^a   Ozlu, Tevfik ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Mortality; Prognosis; Respiratory disease; Troponin

Indexed keywords

C REACTIVE PROTEIN; CARDIAC TROPONIN T; TROPONIN T; UNCLASSIFIED DRUG;

AGED; ARTICLE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; REFERENCE VALUE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 79960682701     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01007     Document Type: Article

References (30)

1. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001;286(19):2405-2412.
2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335(18):1342-1349.
3. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004;125(2):1877-1884.
4. Lazzeri C, Bonizzoli M, Cianchi G, Gensini GF, Peris A. Troponin I in the intensive care unit setting: from the heart to the heart. Intern Emerg Med 2008;3(1):9-16.
5. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27(6):965-969.
6. Stein R, Gupta B, Agarwal S, Golub J, Bhutani D, Rosman A, Eng C. Prognostic implications of normal (<0.10 ng/mL) and borderline (0.10 to 1.49 ng/mL) troponin elevation levels in critically ill patients without acute coronary syndrome. Am J Cardiol 2008;102:509-512.
7. Wu TT, Yuan A, Chen CY, Chen WJ, Luh KT, Kuo SH, et al. Cardiac troponin i levels are a risk factor for mortality and have an additive effect to the APACHE II score in outcome prediction. Shock 2004;22(2):95-101.
8. King DA, Codish S, Novack V, Barski L, Almog Y. The role of cardiac troponin I as a prognostic factor in critically ill medical patients: a prospective observational cohort study. Crit Care 2005; 9(4):390-395.
9. Okamura JM, Miyagi JM, Terada K, Hokama Y. Potential clinical applications of C-reactive protein. J Clin Lab Anal 1990;4(3):431-235.
10. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med 2008; 5(10):621-635.
11. Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H. Chronic inflammatory autoimmune disorders and atherosclerosis. Ann N Y Acad Sci 2007;1107:56-67.
12. Forrester JS, Libby P. The inflammation hypothesis and its potential relevance to statin therapy. Am J Cardiol 2007;99(5):732-738.
13. Grander W, Dünser M, Stollenwerk B, Siebert U, Dengg C, Koller B, et al. CRP Levels and Post-Intensive Care Unit Mortality in Non-Surgical Intensive Care Patients. Chest 2010;138(4):856-862.
14. Ozsu S, Karaman K, Mentese A, Ozsu A, Karahan SC, Durmus I, et al. Combined risk stratification with computerized tomography/ echocardiography and biomarkers in patients with normotensive pulmonary embolism. Thromb Res 2010;126(6):486-492.
15. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 2007;165(6):684-695.
16. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270(24):2957-2963.
17. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS: definitions, mechanism, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3):818-824.
18. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995;21(Suppl 2):258-263.
19. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Me ́lot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123(6):2043-2049.
20. Prieto MF, Kilstein J, Bagilet D, Pezzotto SM. Reactive protein as a marker of mortality in intensive care unit. Med Intensiva 2008;32(9): 424-430.
21. Lim W, Qushmaq I, Devereaux PJ, Heels-Ansdell D, Lauzier F, Ismaila AS, et al. Elevated cardiac troponin measurements in critically ill patients. Arc Intern Med 2006;166(22):2446-2454.
22. Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, Gandini C. Myocardial necrosis in ICU patients with acute noncardiac disease: a prospective study. Intensive Care Med 2000;26(1): 31-37.
23. Martins CS, Rodrigues MJ, Miranda VP, Nunes JP. Prognostic value of cardiac troponin I in patients with COPD acute exacerbation. Neth J Med 2009;67(10):341-349.
24. Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of inhospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med 2008;34(3):481-487.
25. Marsik C, Kazemi-Shirazi L, Schickbauer T, Winkler S, Joukhadar C, Wagner OF, Endler G. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008;54(2):343-349.
26. Minkin R, Cotiga D, Noack S, Dobrescu A, Homel P, Shapiro JM. Use of admission troponin in critically ill medical patients. J Intensive Care Med 2005;20(6):334-338.
27. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):27-72.
28. Vasilyev S, Schaap RN, Mortensen JD. Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units: an international, multicenter, prospective survey. Chest 1995;107(4):1083-1088.
29. Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, Jaffe AS. Elevated cardiac troponin is an independent risk factor for short-and long-term mortality in medical intensive care unit patients. Crit Care Med 2008;36(3):759-765.
30. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003; 107(20):2545-2547.